GLS2 and gastric cancer: GLS2, a glutaminase modulator induced by p53, converts glutamine to glutamate for synthesizing glutathione (Kang et al., 2019), and miR103a3p regulates ferroptosis in gastric cancer cells by altering intracellular glutathione levels.